targeting egfr and lgr5 in head and neck cancer
Published 3 weeks ago • 22 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:36
addition of an egfr/tgfβ inhibitor with pembrolizumab in head and neck cancer
-
3:47
novel therapies for head and neck cancers: bispecific antibodies and fusion proteins
-
50:28
targeting oncogenic pathways in head and neck cancer
-
![[52] egfr-targeted therapy with c225 and cisplatin in patients with head and neck cancer](https://i.ytimg.com/vi/bmg41rkK9aU/mqdefault.jpg)
3:18
[52] egfr-targeted therapy with c225 and cisplatin in patients with head and neck cancer
-
2:01
petosemtamab has promising activity in advanced hnscc
-
3:12
novel immunotherapy approaches in metastatic head and neck cancer
-
8:56
cetuximab safety profile in head and neck cancer
-
3:05
asco 2020: head and neck cancer highlights
-
2:28
palbociclib for platinum-resistant metastatic head and neck cancer
-
1:39
dr. bauml discusses biomarkers in head and neck cancer
-
10:30
expert highlights: targeting her2 and egfr in nsclc | tejas patil
-
1:20
dr. ferris on combining immunotherapy and radiation therapy in head and neck cancer
-
2:21
polymorphism in egfr gene and its association in head and neck cancer patients with tobacco
-
56:51
the wnt target gene lgr5, a marker for adult stem cells in multiple tissues
-
1:09
the unique differences between certain types of head and neck cancer
-
41:19
targeting egfr to enhance nkt cell-mediated killing of lung cancer cells
-
1:40
dr. hisham mehanna on quality of life differences in head and neck squamous cell cancer
-
8:27
egfr-targeted therapy for squamous ncslc
-
1:51
dr. cohen on car t-cell therapy for head and neck cancer